SG Americas Securities
AGN

SG Americas Securities’s Allergan plc AGN Stock Holding History

SG Americas Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-31,700
Closed -$9K – 3781
2019
Q4 		$9K Sell
31,700
-140,000
-82% -$25.3M ﹤0.01% 3184
2019
Q3 		$184K Buy
171,700
+126,000
+276% +$20.5M ﹤0.01% 2400
2019
Q2 		$47K Sell
45,700
-36,000
-44% -$4.98M ﹤0.01% 2923
2019
Q1 		$344K Buy
81,700
+23,600
+41% +$3.42M ﹤0.01% 2157
2018
Q4 		$752K Buy
+58,100
New +$9.52M 0.01% 1560
2018
Q2 		– Sell
-55,600
Closed -$304K – 3644
2018
Q1 		$304K Sell
55,600
-437,300
-89% -$73.4M ﹤0.01% 2172
2017
Q4 		$6.31M Buy
492,900
+386,400
+363% +$69.3M 0.06% 295
2017
Q3 		$1.07M Buy
106,500
+20,100
+23% +$4.67M 0.01% 1206
2017
Q2 		$299K Sell
86,400
-389,800
-82% -$91.6M ﹤0.01% 2172
2017
Q1 		$3.08M Buy
476,200
+360,000
+310% +$83.8M 0.03% 648
2016
Q4 		$2.18M Sell
116,200
-40,000
-26% -$8.29M 0.02% 866
2016
Q3 		$2.07M Buy
156,200
+17,500
+13% +$4.28M 0.02% 716
2016
Q2 		$2.61M Buy
138,700
+87,500
+171% +$20.2M 0.02% 693
2016
Q1 		$910K Buy
51,200
+16,100
+46% +$4.61M 0.01% 1378
2015
Q4 		$12K Buy
+35,100
New +$10.5M ﹤0.01% 2591
2015
Q3 		– Sell
-160,700
Closed -$737K – 2870
2015
Q2 		$737K Buy
+160,700
New +$47.9M ﹤0.01% 1233
2015
Q1 		– Sell
-100,000
Closed -$47K – 3231
2014
Q4 		$47K Hold
100,000
– – ﹤0.01% 3020
2014
Q3 		$780K Buy
+100,000
New +$22.4M ﹤0.01% 1264

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

SG Americas Securities's AGN Position: Q2 2020 in Review

SG Americas Securities sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 80,536 shares — an estimated $14.3M sold.

SG Americas Securities first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $46.4M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • SG Americas Securities reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • SG Americas Securities sold 80,536 Allergan plc shares in Q2 2020, an estimated $14.3M.
  • SG Americas Securities first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • SG Americas Securities's Allergan plc position peaked at $46.4M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on SG Americas Securities's 13F filing for Q2 2020, filed 20 Jul 2020.